StockData
Adial Pharmaceuticals, Inc. logo

Adial Pharmaceuticals, Inc. (AZR) stock

AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.80+0.13 (+3.68%)

Close on Nov 18, 2026Market cap $9.98MP/E –Yield –

Earnings

Adial Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 5, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
$4.52
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Adial Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 5, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close––$4.52Release
Q2 FY2026ended Jun 30, 2026Aug 17, 2026before the open––-$11.25Release
Q1 FY2026ended Mar 31, 2026May 11, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 6, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023after the close–––Release
Q2 FY2023ended Jun 30, 2023Aug 21, 2023before the open–––Release
Q1 FY2023ended Mar 31, 2023May 12, 2023after the close–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Adial Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Adial Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Adial Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. News
  4. Results
  5. Update
  6. Update
  7. Results
  8. Results
  9. Update
  10. News
  11. News
  12. News
  13. Results
  14. Update
  15. Results

See a number that looks wrong?